Stocks of Ocugen Inc (NASDAQ:OCGN) traded higher last session on Wall Street, up 4.94% to $0.58.
OCGN stock price is now -14.98% away from the 50-day moving average and -45.45% away from the 200-day moving average. The market capitalization of the company currently stands at $168.20M.
With the price target of $4, Maxim Group recently initiated with Buy rating for Ocugen Inc (NASDAQ: OCGN). On March 01, 2023, Chardan Capital Markets Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $3.50, while ‘Mizuho’ rates the stock as ‘Buy’
In other news, Fernandes Prabhavathi, Director bought 10,000 shares of the company’s stock on Nov 26 ’24. The stock was bought for $9,095 at an average price of $0.91. Upon completion of the transaction, the Director now directly owns 10,000 shares in the company, valued at $5800.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 22 ’24, Director Castillo Kirsten bought 25,000 shares of the business’s stock. A total of $22,848 was incurred on buying the stock at an average price of $0.91. This leaves the insider owning 75,000 shares of the company worth $43500.0. A total of 1.80% of the company’s stock is owned by insiders.
During the past 12 months, Ocugen Inc has had a low of $0.51 and a high of $2.11. As of last week, the company has a debt-to-equity ratio of 1.10, a current ratio of 2.86, and a quick ratio of 2.86. The fifty day moving average price for OCGN is $0.67752 and a two-hundred day moving average price translates $1.05593 for the stock.
The latest earnings results from Ocugen Inc (NASDAQ: OCGN) was released for 2024-12-31. The net profit margin was -1210.06% and return on equity was -154.01% for OCGN. The company reported revenue of $0.76 million for the quarter, compared to $1.41 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -45.78 percent.
